ENZN stock forecast
Our latest prediction for Enzon Pharmaceuticals, Inc.'s stock price was made on the Aug. 5, 2020 when the stock price was at 0.20$.
In the short term (2weeks), ENZN's stock price should outperform the market by 5.12%. During that period the price should oscillate between -8.43% and +18.87%.
In the medium term (3months), ENZN's stock price should outperform the market by 21.76%. During that period the price should oscillate between -26.86% and +48.40%.Get email alerts
Create a solid portfolio with ENZN
About Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.02$ per share.
The book value per share is 0.18$
Three months stock forecastAug. 5, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|